The USPSTF of USA recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years.
What are the Clinical Considerations for discussion of cytology method, HPV testing, and screening interval?
What should be done in the resource-poor countries?